Comparison of the metabolic and economic consequences of long-term treatment of schizophrenia using ziprasidone, olanzapine, quetiapine and risperidone in Canada: a cost-effectiveness analysis
2010 ◽
Vol 16
(4)
◽
pp. 744-755
◽
Keyword(s):
Keyword(s):